
8-Year Data Confirms Durability of Edwards’ RESILIA Tissue
8-Year Data Confirms Durability of Edwards’ RESILIA Tissue Edwards Lifesciences (NYSE: EW) has announced compelling new eight-year data demonstrating that patients who received surgical aortic valves made with the company’s…












